In This Article:
In a week marked by volatility and mixed economic signals, the S&P 600 Index for small-cap stocks has mirrored broader market fluctuations, reflecting concerns over growth and consumer demand. Amidst this backdrop, identifying undervalued small-cap stocks with insider action can present unique opportunities for investors seeking to enhance their portfolios. A good stock in these conditions often exhibits strong fundamentals and insider buying activity, which can signal confidence from those closest to the company.
Top 10 Undervalued Small Caps With Insider Buying
Name | PE | PS | Discount to Fair Value | Value Rating |
---|---|---|---|---|
Bytes Technology Group | 24.9x | 5.6x | 11.43% | ★★★★★☆ |
Nexus Industrial REIT | 2.7x | 3.3x | 22.31% | ★★★★★☆ |
AtriCure | NA | 2.7x | 40.03% | ★★★★★☆ |
Lindblad Expeditions Holdings | NA | 0.7x | 47.41% | ★★★★★☆ |
Citizens & Northern | 12.7x | 2.8x | 44.41% | ★★★★☆☆ |
PCB Bancorp | 11.1x | 2.8x | 42.01% | ★★★★☆☆ |
CVS Group | 22.5x | 1.2x | 40.63% | ★★★★☆☆ |
MYR Group | 34.3x | 0.5x | 41.93% | ★★★☆☆☆ |
Community West Bancshares | 18.7x | 2.9x | 42.25% | ★★★☆☆☆ |
Delek US Holdings | NA | 0.1x | -107.44% | ★★★☆☆☆ |
We're going to check out a few of the best picks from our screener tool.
NRW Holdings
Simply Wall St Value Rating: ★★★★☆☆
Overview: NRW Holdings is an Australian-based company providing civil construction, mining services, and urban infrastructure solutions with a market cap of approximately A$1.20 billion.
Operations: NRW Holdings generates revenue primarily through its core operations, with the cost of goods sold (COGS) and operating expenses being significant components of its financial structure. The company has seen fluctuations in its net income margin, which was -0.29% for the quarter ending 2015-09-30 and improved to 3.57% by 2024-06-30. Over recent periods, NRW's gross profit margin has ranged from a low of 41.30% to a high of 48.43%.
PE: 15.4x
NRW Holdings, a small player in the construction and mining services sector, recently reaffirmed its revenue guidance for fiscal year 2024 at A$2.9 billion. On August 15, they reported earnings aligning with expectations. Notably, insider confidence is evident with recent share purchases by executives over the past three months. Despite reliance on external borrowing for funding, projected annual earnings growth of 9.45% indicates potential for future value appreciation.
-
Take a closer look at NRW Holdings' potential here in our valuation report.
-
Explore historical data to track NRW Holdings' performance over time in our Past section.
AtriCure
Simply Wall St Value Rating: ★★★★★☆
Overview: AtriCure specializes in developing and selling surgical and medical equipment, with a market cap of approximately $2.20 billion.